Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study
A single-center cross-sectional study was conducted to describe the use of ceftaroline in a large teaching hospital in Northern Italy, during a period also including the first months of the coronavirus disease 2019 (COVID-19) pandemic. The primary objective was to describe the use of ceftaroline in...
Main Authors: | Daniele Roberto Giacobbe, Chiara Russo, Veronica Martini, Silvia Dettori, Federica Briano, Michele Mirabella, Federica Portunato, Chiara Dentone, Sara Mora, Mauro Giacomini, Marco Berruti, Matteo Bassetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/7/763 |
Similar Items
-
The Role of ArlRS and VraSR in Regulating Ceftaroline Hypersusceptibility in Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Maite Villanueva, et al.
Published: (2021-07-01) -
Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
by: Gianluca Morroni, et al.
Published: (2021-08-01) -
Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
by: Harsha Sreedharan, et al.
Published: (2021-01-01) -
Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01) -
In Vitro Activity Of Ceftaroline And Comparators Against Staphylococcus aureus Isolates: Results From 6 Years Of The ATLAS Program (2012 To 2017)
by: Zhang Z, et al.
Published: (2019-10-01)